Toho Holdings Co Ltd
TSE:8129

Watchlist Manager
Toho Holdings Co Ltd Logo
Toho Holdings Co Ltd
TSE:8129
Watchlist
Price: 4 353 JPY -2.7% Market Closed
Market Cap: ¥307.1B

P/FCFE

96.2
Current
1 799%
More Expensive
vs 3-y average of 5.1

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
96.2
=
Market Cap
¥308.4B
/
Free Cash Flow to Equity
¥2.9B

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
96.2
=
Market Cap
¥308.4B
/
Free Cash Flow to Equity
¥2.9B

Valuation Scenarios

Toho Holdings Co Ltd is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (5.1), the stock would be worth ¥229.21 (95% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-95%
Maximum Upside
No Upside Scenarios
Average Downside
83%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 96.2 ¥4 353
0%
3-Year Average 5.1 ¥229.21
-95%
5-Year Average 5.7 ¥257.91
-94%
Industry Average 31.8 ¥1 440.82
-67%
Country Average 22.4 ¥1 011.56
-77%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close
Market Cap P/FCFE P/E
JP
Toho Holdings Co Ltd
TSE:8129
281.6B JPY 96.2 11.7
US
Mckesson Corp
NYSE:MCK
100.1B USD 12.5 23.1
US
Cencora Inc
NYSE:COR
59.1B USD 19.7 36.4
US
Amerisourcebergen Corp
LSE:0HF3
59.5B USD 19.8 36.6
US
Cardinal Health Inc
NYSE:CAH
46.1B USD 6.8 27.7
AU
Sigma Healthcare Ltd
ASX:SIG
32.3B AUD 40.9 35.5
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.4B CNY 21.6 11.1
US
Henry Schein Inc
NASDAQ:HSIC
8.6B USD 8.9 21.5
CN
Huadong Medicine Co Ltd
SZSE:000963
58.5B CNY 136.2 20.6
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW -236.8 89.6
CN
Sinopharm Group Co Ltd
HKEX:1099
57.6B HKD -35.6 7.2

Market Distribution

Higher than 90% of companies in Japan
Percentile
90th
Based on 3 849 companies
90th percentile
96.2
Low
0.1 — 14.9
Typical Range
14.9 — 35
High
35 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 14.9
Median 22.4
70th Percentile 35
Max 736 044 589.7

Toho Holdings Co Ltd
Glance View

Market Cap
307.1B JPY
Industry
Health Care

Toho Holdings Co., Ltd., founded in the bustling heart of Japan, is a keystone in the healthcare distribution industry, orchestrating the intricate dance between pharmaceutical manufacturers and frontline healthcare providers. This Tokyo-based conglomerate has adeptly positioned itself as a pivotal node in the healthcare supply chain, ensuring that lifesaving medications and medical supplies reach pharmacies, hospitals, and other medical institutions efficiently and effectively. Toho Holdings thrives on its robust distribution network, leveraging advanced logistics systems to manage and deliver an extensive range of pharmaceutical products across the nation. The efficiency of its supply chain operations not only cements its reputation but also stands as a testament to its role as a reliable partner within Japan's healthcare landscape. Beyond its logistics prowess, Toho Holdings is deeply invested in adding value across the entire pharmaceutical distribution process. Its operations are intricately designed to capitalize on economies of scale, which aids in maintaining competitive pricing and ensuring steady demand fulfillment. Revenue streams flow predominantly from its core business of pharmaceutical wholesale, enhanced by an array of services such as inventory management, consulting, and digital solutions that cater to the increasingly complex needs of healthcare providers. Moreover, Toho Holdings extends its influence through strategic alliances and partnerships, aligning with global players to stay ahead in innovation and market trends. This approach not only fortifies its business operations but also solidifies its commitment to being an indispensable link in the healthcare delivery chain, effectively balancing the dynamics between commerce and the critical demand for healthcare services.

Intrinsic Value
6 390.46 JPY
Undervaluation 32%
Intrinsic Value
Price ¥4 353
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett